Quidel Corporation operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Quidel with three other
pharmaceutical manufacturers in North America:
sales of $180.83 million
of which 100%
was Protandim), and
Meridian Bioscience, Inc.
of which 75%
was US Diagnostics).
Quidel reported sales of $196.13 million
December of 2015.
increase of 7.4%
versus 2014, when the company's sales were $182.62 million.
This was the third consecutive year of growth at Quidel.